Cargando…

Efficacy and safety of danoprevir plus sofosbuvir in GT 1, 2, 3, or 6 chronic hepatitis C patients with or without cirrhosis in China

All-oral direct-acting antiviral therapies are becoming the choice for hepatitis C (HCV) treatment. In this study, we aimed to evaluate the efficacy and safety of ritonavir-boosted danoprevir (DNVr) plus sofosbuvir±ribavirin on HCV genotype 1, 2, 3, or 6 in the real world in China. In this observati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Shufang, Feng, Kai, Huang, Ping, Zeng, Yingfu, Ke, Liu, Yang, Xiaodong, Liu, Jing, Lin, Chaoshuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213259/ https://www.ncbi.nlm.nih.gov/pubmed/34128871 http://dx.doi.org/10.1097/MD.0000000000026312

Ejemplares similares

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients
por: Chen, Hongyi, et al.
Publicado: (2020)

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
por: Mohamed Abdelnajid, Doaa, et al.
Publicado: (2023)

Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study
por: An, Yang, et al.
Publicado: (2021)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
por: Flamm, Steven, et al.
Publicado: (2023)

Evaluation of prognostic scoring systems in liver cirrhosis patients with bloodstream infection
por: Zhao, Hong, et al.
Publicado: (2017)

Multiple Brain Abscesses Due to Aspergillus Fumigatus in a Patient With Liver Cirrhosis: A Case Report
por: Tang, Hung-Jen, et al.
Publicado: (2016)

The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China
por: Gao, Qijun, et al.
Publicado: (2020)

Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis
por: Shah, Islam, et al.
Publicado: (2021)

Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
por: Zhu, Bo, et al.
Publicado: (2021)

Sofosbuvir based therapy in hepatitis C patients with and without cirrhosis: Is there difference?
por: Sarwar, Shahid, et al.
Publicado: (2017)

Association between liver cirrhosis and estimated glomerular filtration rates in patients with chronic HBV infection
por: Wang, Dexin, et al.
Publicado: (2020)

Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy
por: Miao, Miao, et al.
Publicado: (2020)

The efficacy and safety of fire needle therapy for COVID-19: Protocol for a systematic review and meta-analysis
por: Liu, Min, et al.
Publicado: (2020)

Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C
por: Wei, Lai, et al.
Publicado: (2019)

Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics
por: Wang, Yang, et al.
Publicado: (2021)

Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis
por: Liu, Zhongping, et al.
Publicado: (2021)

Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults
por: Guan, Yanmin, et al.
Publicado: (2020)

HLA-DPB1 alleles in hepatitis B vaccine response: A meta-analysis
por: Ou, Guojin, et al.
Publicado: (2021)

Kinetic Changes of Viremia and Viral Antigens of Hepatitis B Virus During and After Pregnancy
por: Liu, Jingli, et al.
Publicado: (2015)

Association between serum Cystatin C and renal injury in patients with chronic hepatitis B
por: Zheng, Hui, et al.
Publicado: (2020)

Hepatitis C virus genotype and subtype distribution among ethnic minorities in Liaoning Province of China
por: Li, Rongkuan, et al.
Publicado: (2021)

Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, China
por: Jiao, Yang, et al.
Publicado: (2016)

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019)

Decrease of 5-hydroxymethylcytosine in hepatitis B virus-related hepatocellular carcinoma: A cross-sectional study
por: Jia, Yansheng, et al.
Publicado: (2023)

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)

Effects and safety of tanreqing injection on viral pneumonia: A protocol for systematic review and meta-analysis
por: Liu, Hui, et al.
Publicado: (2020)

Effectiveness of direct-acting antivirals for hepatitis C virus infection in hepatitis C/HIV coinfected individuals: A multicenter study
por: Machado, Soraia M., et al.
Publicado: (2020)

Epidemiological characteristics of hepatic echinococcosis, concurrent cerebral echinococcosis, and pulmonary echinococcosis in Ganzi County, Sichuan Province, China
por: Ma, Li, et al.
Publicado: (2020)

A PRISMA-compliant systematic review and meta-analysis of integrated Chinese and Western medicine in treating hepatitis C
por: Li, Xiuqin, et al.
Publicado: (2020)

Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Liu, Yan, et al.
Publicado: (2020)

Four weeks of paritaprevir/ritonavir/ombitasvir plus dasabuvir encountering dengue fever resulted in sustained virological response in an HCV patient: A case report
por: Huang, Chung-Feng, et al.
Publicado: (2016)

Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: A case report
por: Jang, Hyunil, et al.
Publicado: (2018)

Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
por: Loo, Jing Hong, et al.
Publicado: (2022)

Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Liu, Yan, et al.
Publicado: (2020)

Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis
por: Liu, Nanyang, et al.
Publicado: (2020)

The genotype analysis of the hepatitis C virus in Heilongjiang Province, China
por: Cheng, Xue-Di, et al.
Publicado: (2021)

Characteristics and outcome of spontaneous bacterial meningitis in patients with cancer compared to patients without cancer
por: Pomar, Virginia, et al.
Publicado: (2017)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pt0i1le9pr1snmbiik8j9iffa9